Vitamin D3 Treatment and Homocysteine Concentrations Among Overweight Reproductive Women
Status:
Completed
Trial end date:
2016-10-30
Target enrollment:
Participant gender:
Summary
100 overweight reproductive vitamin D deficient women were divided into two groups; vitamin D
(n = 50) and placebo (n = 50). Vitamin D group received treatment dose of 50,000 IU of
vitamin D3 per week for 2 consecutive months and placebo group received placebo tablets
similar in size, shape and color to vitamin D3 for 2 months also. Total homocysteine
concentrations were measured before intervention (basal), on 30 days (one month) and on 60
days (2 months) of intervention. Changes in means of homocysteine concentrations for placebo
and vitamin D group over time showed significant difference on 30 and 60 days of
intervention. Mean comparisons of homocysteine concentrations and standard error of the means
before and after intervention showed statistical significant decrease in homocysteine
concentrations among vitamin D group.
Phase:
Phase 2
Details
Lead Sponsor:
Al-Balqa Applied University
Collaborator:
Jordan University of Science and Technology
Treatments:
Cholecalciferol Ergocalciferols Vitamin D Vitamins